- +159.7% price growth over the last year
- Low bankruptcy risk (Altman Z-Score: 199.00)
- Bullish trend confirmed on both short and long timeframes
On Tuesday, Trevi Therapeutics Inc. stock price gained an impressive 8.41%
(Updated on Jul 21, 2026)
The Trevi Therapeutics Inc. stock price gained 8.41% on the last trading day (Tuesday, 21st Jul 2026), rising from $16.77 to $18.18. During the last trading day the stock fluctuated 7.35% from a day low at $17.01 to a day high of $18.26. The price has fallen in 6 of the last 10 days and is down by -6.77% for this period. Volume fell on the last day by -631 thousand shares and in total, 2 million shares were bought and sold for approximately $40.16 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 33.16% during the next 3 months and, with a 90% probability hold a price between $20.80 and $27.07 at the end of this 3-month period.
TRVI Signals & Forecast
There are mixed signals in the stock today. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -6.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). The Trevi Therapeutics Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $17.71 and $16.51. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely.
Support, Risk & Stop-loss for Trevi Therapeutics Inc. stock
Trevi Therapeutics Inc. finds support from accumulated volume at $18.15 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.25 between high and low, or 7.35%. For the last week, the stock has had daily average volatility of 10.49%.
Our recommended stop-loss: $17.29 (-4.89%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 10 days ago.)
Trading Expectations (TRVI) For The Upcoming Trading Day Of Wednesday 22nd
For the upcoming trading day on Wednesday, 22nd we expect Trevi Therapeutics Inc. to open at $17.82, and during the day (based on 14 day Average True Range), to move between $17.53 and $18.83, which gives a possible trading interval of +/-$1.30 (+/-7.44%) up or down from last closing price. If Trevi Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 7.44% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $18.15 (0.17%) than the resistance at $18.65 (2.59%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Trevi Therapeutics Inc. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Trevi Therapeutics Inc. stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
1.918
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 22, 2026 - $17.82 ( 2.00%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
TRVI Performance
Trading levels for TRVI
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 19.07 | 4.88% |
| R2 | 18.59 | 2.25% |
| R1 | 18.29 | 0.628% |
| Price | 18.18 | |
| S1 | 17.34 | -4.63% |
| S2 | 17.04 | -6.25% |
| S3 | 16.57 | -8.87% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 19.50 | 7.26% |
| R2 | 19.07 | 4.90% |
| R1 | 18.65 | 2.59% |
| Price | 18.18 | |
| S1 | 18.15 | -0.165% |
| S2 | 18.00 | -0.99% |
| S3 | 17.52 | -3.63% |
FAQ
Click here for our free guide on how to buy Trevi Therapeutics Inc. Stock.
Buy TRVI